Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
SGX News
81 Leser
Artikel bewerten:
(0)

HEALTHWAY MEDICAL CORPORATION LIMITED: Change - Announcement of Appointment

ReferenceSG140403OTHRE2HD
Message ReferenceZKG489DUEX2LVUV9
Issuer
NameHEALTHWAY MEDICAL CORPORATION LIMITED
StatusActive
Country of IncorporationSG
Company Registration Number200708625C
Issuer Address24 Raffles Place #19-01 Clifford Centre
Singapore
SG
048621
Issuer Phone8163 8822
Security
ImplementationcodeIMPL_SGX
Long NameHEALTHWAY MEDICAL CORP LTD
Short NameHEALTHWA
Sequencenumber1
StatuscodeActive
MarketcodeCATALIST
Identifiers
IdentifierIBM Code
1X09
IdentifierStock Code
5NG
IdentifierHP Short Name
Healthway
IdentifierIBM Short Name
HEALTHWAY
IdentifierMaster Code
42418
IdentifierISIN
SG1X09940682
Security TypeOrdinary Share
Trading CurrencySGD
Par CurrencySGD
Place of Listing
Place ValueXSCA
Classification TypeOrdinary Shares
Announcement TypeAnnouncement of Appointment
Message FunctionNew
Announcement TitleChange - Announcement of Appointment
Announcement SubtitleAPPOINTMENT OF FINANCIAL CONTROLLER
Submitted ByFan Kow Hin
DesignationExecutive Chairman
Flags
FlagShareholding Interestfalse
FlagPrior Experience As Directorfalse
Dates
DateAnnouncement Date/ Time2014-04-03T18:30:22
DateAppointment Date2014-04-03T00:00:00
Market Acquisition Details
Off Market Acquisition Details
Age53
Principal Resident CountrySG
Queries for Appointment Event
Queries and ResponseIDAnnouncement Appointment Question No. 1
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 2
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 3
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 4
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 5
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 6
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 7
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 8
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 9
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 10
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 11
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 12
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 13
Description
Response
Queries and ResponseIDAnnouncement Appointment Question No. 14
Description
Response
Narratives
NarrativePerson Name
Woo Yok Yuen
NarrativeBoard Comments
The Nominating Committee and the Board of Directors (Board), having reviewed the qualifications, experience and suitability of Ms Woo Yok Yuen ("Ms Woo"), is satisfied that Ms Woo possess the requisite qualifications and work experiences for the position of Financial Controller. On the recommendation by the Nominating Committee, the Board approved the appointment of Ms Woo as Financial Controller.
NarrativeJob Title
Financial Controller
NarrativeWorking Experience
Please see Annexure A
NarrativeConflict Of Interest
Nil
NarrativeFamilial RelationShip
Nil
NarrativeOther DirectorShips Past
Nil
NarrativeOther DirectorShips Present
Nil
NarrativeDirector Experience Details
Not Applicable
NarrativeEvent Description
This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this announcement. This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Mr Mark Liew, Managing Director, Corporate Finance, at 20 Cecil Street, #21-02, Equity Plaza, Singapore 049705, telephone 65-62298088.
Attachments
Attachment20140403_183022_5NG_ZKG489DUEX2LVUV9.1.pdf
Purpose: External / Sequence: 1
Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2014 SGX News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.